Valuation: Novartis AG

Market Cap 303B 266B 248B 228B 427B 28,975B 435B 2,940B 1,151B 14,370B 1,139B 1,114B 49,647B P/E 2026 *
22.7x
P/E 2027 * 19.3x
Enterprise Value 336B 295B 275B 253B 474B 32,138B 482B 3,262B 1,277B 15,938B 1,263B 1,236B 55,067B EV / Sales 2026 *
5.84x
EV / Sales 2027 * 5.42x
Free-Float
91.66%
Yield 2026 *
2.74%
Yield 2027 * 2.86%
1 day-0.13%
1 week+3.80%
Current month+2.78%
1 month+3.09%
3 months+14.79%
6 months+13.84%
Current year+18.70%
1 week 122.56
Extreme 122.56
131.5
1 month 121.06
Extreme 121.06
131.5
Current year 107.68
Extreme 107.68
131.5
1 year 91.56
Extreme 91.56
131.5
3 years 81.1
Extreme 81.1
131.5
5 years 72.84
Extreme 72.84
131.5
10 years 65.09
Extreme 65.09
131.5
Manager TitleAgeSince
Chief Executive Officer 50 31/01/2018
Director of Finance/CFO - 15/03/2026
Chief Tech/Sci/R&D Officer 64 15/05/2022
Director TitleAgeSince
Director/Board Member 67 31/12/2014
Director/Board Member 69 31/12/2015
Director/Board Member 61 31/12/2015
Date Insider Type Main position Quantity % Market Cap.
18/05/26 Sell -5,200 0.0003%
04/05/26 Sell 6,800 0.0003%
17/02/26 Sell 30,743 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-0.12%+3.80%+37.35%+42.86% 303B
+1.93%+3.85%+51.05%+166.24% 1,089B
+0.29%+6.43%+60.47%+52.87% 643B
+2.45%+2.77%+39.61%+74.48% 465B
-0.39%+10.17%+41.12%+35.33% 359B
+1.25%+3.20%+17.48%+17.18% 267B
+0.22%+5.21%-3.10%-38.45% 226B
+4.48%+7.33%+30.47%+66.31% 212B
+2.91%+3.10%+18.84%+74.76% 167B
+2.35%+1.24%+3.87%-30.00% 144B
Average +0.64%+4.53%+29.72%+46.16% 387.5B
Weighted average by Cap. +0.25%+4.94%+39.51%+75.71%

Financials

2026 *2027 *
Net sales 57.58B 50.54B 47.06B 43.28B 81.14B 5,501B 82.53B 558B 219B 2,728B 216B 212B 9,426B 61.12B 53.64B 49.95B 45.94B 86.13B 5,839B 87.6B 593B 232B 2,896B 229B 225B 10,006B
Net income 13.78B 12.09B 11.26B 10.36B 19.42B 1,317B 19.75B 134B 52.3B 653B 51.73B 50.62B 2,256B 15.36B 13.48B 12.55B 11.54B 21.64B 1,467B 22.01B 149B 58.28B 728B 57.66B 56.41B 2,514B
Net Debt 33.11B 29.06B 27.06B 24.89B 46.66B 3,164B 47.46B 321B 126B 1,569B 124B 122B 5,421B 27.82B 24.41B 22.73B 20.91B 39.2B 2,658B 39.87B 270B 106B 1,318B 104B 102B 4,554B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
29/07/26 CHF 130.10 -0.23% 1,014,391
28/07/26 CHF 130.40 +1.46% 2,558,238
27/07/26 CHF 128.52 +1.28% 2,435,055
24/07/26 CHF 126.90 -0.60% 1,859,367
23/07/26 CHF 127.66 +1.85% 2,482,939
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
159.56USD
Average target price
153.99USD
Spread / Average Target
-3.49%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock